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In recent years, lasers are being utilized in cardiovascular surgery. Since the 1980’ s we have inves-
tigated angioplasty using an Argon laser for patients with obstructive arterial diseases. This tech-
nique aims to open the obstructive arterial lumen. Based on the excellent results of experimental
studies, the technique has been clinically applied. Laser angioplasty was carried out in 84 patients
with stenotic or obstructive lesions occluding more than 75% of peripheral and coronary arteries an-
giographically. They consisted of 74 cases with intermittent claudication and 10 cases with angina
pectoris. Laser angioplasty for the peripheral arterial disease was performed under local anesthesia
in the inguinal region under angioscopic guidance. On the other hand, laser coronary angioplasty was
simultaneously undertaken at the time of coronary artery bypass grafting for a patient with multiple
coronary stenoses. The initial success rate by laser angioplasty for the peripheral artery was 91% in
the stenotic lesions and 71% in the obstructive lesions. The cumulative patency rate was 94% in the
stenotic lesions and 83% in the occlusive lesions. A follow-up study of 66 months was carried out
for patients with clinical success, excluding the cases where an angiogram showed occlusion within
week after laser angioplasty. Consequently, excellent long-term results could be clinically obtained.
Based on the satisfactory results in the peripheral artery, coronary laser angioplasty was employed
in 10 patients with angina pectoris. There were no complications by laser. Thus, the feasibility of
laser application was apparently confirmed and laser angioplasty might be recommended for patients
with atherosclerotic changes, especially for small arteries.
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INTRODUCTION
In recent years, endovascular interventions such as bal-
loon angioplasty, atherectomy and the stenting method
have been clinically applied for patients with atheroma-
tous plaques of the peripheral- and the coronary arteries
(1,3). Among them, restenosis after endovascular inter-
vention has been obviously confirmed in 30-40% of the
patients who underwent percutaneous transluminal coro-
nary angioplasty (2). However, there are some problems
in maintaining long-term patency by means of endovas-
cular techniques such as balloon techniques and atherec-
tomy. For these problems, we have experimentally
investigated the effect of an Argon laser on vaporization
of the atheromatous plaques. Based on our excellent ex-
perimental studies, a laser was utilized for patients with
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intermittent claudication, angina pectoris, and ischemic
ulcer of the lower extremity. Subsequently, the feasibility
of laser angioplasty could be disclosed in the field of car-
diovascular surgery (4).
MATERIALS AND METHODS
In cardiovascular surgery, Argon, Nd-YAG, Ho-YAG and
Excimer lasers have been widely employed all over the
world. An Argon laser (Trimedyne/Laser Ionics, Model
5567, and HGM, Endocoagulator Model 20S, USA) was
utilized for the vaporizing of atherosclerotic plaques in
this study (4). Animal care was in compliance with the
"Principles of Laboratory Animal Care" and the "Guide
forCare andUse ofLaboratory Animals" (NIH Publication
No. 80-23, revised 1985).
First of all, the relationship between laser energy and
reactions of the aortic walls to the laser was experimen-
tally evaluatedusing adultmongrel dogs.Ametal tipprobe
(LaserprobePLR-Flex orLaserprobePLR-Plus,Trimedyne12 M. OKADA et al.
Inc. CA, USA) was mainly used. Consequently, it could
be confirmed that optimal conditions for laser angioplasty
were 6W in output and 3 sec in irradiation time for each
shot. On the other hand, a metal tip probe with thermal
feedback control system (HGM, Endocoagulator, Model
20S, and Laserprobe, PLAC, HGM, Salt Lake City, UT
USA) was applied, for which the adequate tip temperature
for vaporizing the atheromatous plaques was 200C and
the irradiation time was 5 sec for each shot. These condi-
tions were almost the same laser energy for adequacy, that
is, in the case with 6W and 3 sec using the MTP, the inti-
mal layerwas vaporized, and with8W and 3 sec, the crater
reached the media. Then, with 8W and 3 sec using the
BEP, arterial perforation occurred immediately. On the
other hand, in the case with thermal feedback control sys-
tem the arterial crater was deepened by an increase in the
temperature of the MTP (Fig. 1). In the case with
100--150C in the temperature ofthe MTP, the intimal sur-
face was slightly vaporized, with 200--300C, the crater
reached deeper initimal layer. In the case with more than
300C, the mediawas also vaporized. Consequently, itwas
considered that suitable temperature of the MTP was
200C.
At the time of laser angioplasty, the use of an angio-
scope was inevitable for observing the inside of the ar-
teries before and after laser irradiation (1). At present,
laser angioplasty has been carried out for 84 patients with
atherosclerotic changes of the peripheral and coronary
arteries. This includes 70 men and 14 women, ranging in
age from 36- to 81-years-old with an average of 65.7 +
9.8. These patients consisted of 71 cases with intermit-
tent claudication, 2 cases with rest pain and one case with
a refractory ulcer in the leg, including 10 cases with
angina pectoris.
(a) (b)
Figure 1 Laser energy and microscopic reactions of the arterial wall a) With metal tip probe b) With metal tip probe included thermal feedback control
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Angiography for the peripheral and coronary arteries
was undertaken in all patients and their operative indica-
tion was clearly decided by clinical symptoms and angio-
graphic findings with severe stenosis ofmore than 75% of
the internal diameter and total occlusion ofthe arteries (1).
The length of occlusive and stenotic lesions in the pe-
ripheral arteries ranged from 0.5 cm to 45 cm with a mean
of 7.6 _+ 8.8 cm.
As the method of laser angioplasty, a sheath catheter
was percutaneously inserted proximally for the iliac le-
sions and distally for the femoral and popliteal lesions
under local anesthesia in the inguinal region. After this
procedure, an angioscope (0.75 mm in diameter) was in-
serted through the sheath catheter and the surface of the
atherosclerotic plaques in the artery was observed. At this
time, it is very important to wash out the blood with saline
for clear observation. Through this procedure, the inside
of the artery could be precisely observed. There are sev-
eral sizes of angioscope, such as 0.75 mm or 0.45 mm in
diameter. From the standpoint of image clarification, an
angioscope of 0.75 mm in diameter was the most useful
instrument.. Thereafter, laser irradiation was carefully ini-
tiated to make a laser hole for the occlusive lesion under
angioscopic guidance using a bare-ended laser fiber and
metal tip probe. In the case with a calcified occlusion at
the site ofthe femoral artery, this artery was first exposed
and a sheath catheter was directly inserted to the athero-
matous plaques under direct vision. A guide-wire was
then passed through a laser hole which was previously
created using a bare-ended laser fiber. Then laser abla-
tion was carefully performed using a metal tip probe
(2.0-2.5 mm in diameter) inserted over the guide-wire.
In this study, 6W in output and 3 sec in irradiation time,
or 200C and 5 sec using a metal tip probe with thermal
feedback control system were utilized as optimal condi-
tions for each laser ablation. Laser ablations were con-
tinued toeliminateatheromatous plaques underangioscopic
and fluoroscopic guidance, until recanalization and a
wide opening of the vessel lumen could be observed.
Consequently, the conditions of6W and 3 sec were ap-
plied for23 patients. For the remaining 51 cases, the feed-
back control system was employed. Moving the metal tip
probe slowly in the artery, it is very important to prevent
vasoconstriction and fragmentation of the atheromatous
plaques during laser ablation. Then, in cases where di-
latation was inadequate by lasing, percutaneous translu-
minal angioplasty (PTA) was additionally undertaken.
All clinical results were expressed as the mean standard
deviation. The unpaired t-test was used to test for dif-
ferences in variables between the two measurements,
and a P-value less than 0.05 was accepted as statistically
significant.
RESULTS
1) Laser Angioplasty For Peripheral Arterial Diseases
At present, 74 patients (93 lesions) have been treated by
laser angioplasty. This includes 61 men and 13 women
who had intermittent claudication, rest pain, and refrac-
tory limb ulcers. They consisted of 73 patients with arte-
riosclerosis obliterans and only one with thromboangitis
obliterans.
Forty-oneamong 93 lesions were in the lilac region, and
48 lesions existed in the femoro-popliteal region. The re-
maining 4 lesions were thrombogenic stenoses of im-
planted vascular grafts and the anastomotic site of the
saphenous vein after coronary artery bypass grafting.
Forty-four lesions revealed stenotic changes, and 49 le-
sions showed obstructive findings. The length of lesions
ranged from 0.5 cm to 45.0 cm with a mean of 7.6 cm in
length by angiography (Table 1). The criteria of clinical
success were evaluated as follows: a) relief of symptom,
b) improvement of arterial pulsation, c) increase of ankle
pressure index of more than 0.2, and d) residual stenosis
of less than 50% in the internal diameter of the lased ar-
teries. Basedon these examinations, all cases were strictly
evaluated. Subsequently, a success rate of 91% could be
found in the cases with stenotic lesions. On the contrary,
the success rate was 71% in the cases with occlusive le-
sions (Table 2). Further, from the length of the lesion, a
clinical success rate of97% was observedeven in the cases
with femoro-popliteal lesions within 10cm in length (Fig.
2). However, in the cases with lesions of more than 10cm
in length, the rate decreased to 75%.
On the other hand, a clinical success rate of 86% was
obtained in the cases with iliac lesions of less than 5 cm
in length. Thus, there were significant differences in com-
parison with the success rate and the length of the lesion
Table 1 Patient Characteristics of Laser Angioplasty for Chronic
Obstructive Arterial Diseases
Case 74 cases (87 limbs, 93 lesions)
Gender Male 61 cases, Female 13 cases
Age 43 82 Y (65.7 _+ 9.8 Y)
Disease ASO 73 cases, TAO case
Chief Intermittent claudication 71 cases
Complaint Rest pain 2 cases
Refractory ulcer case
Location lliac 41 lesions
Fem-pop. 48 lesions
Prosthetic graft stenosis lesion
Graft stenosis lesion
SVG graft stenosis 2 lesions
Severity Occlusions 49 lesions
Stenosis 44 lesions
Length 0.5 45 cm (7.6 + 8.8 cm)
(Kobe Univ. Surg II: 93.6)14 M. OKADA et al.
a)
b) (1) (2) (3)
Figure 2 Percutaneous laser angioplasty for the peripheral artery, a) Laser angioplasty for the occlusion of the left common iliac artery, b) Laser
angioplasty for the occlusion of the right superficial femoral artery under intravascular ultrasound (1) before lasing (2) after lasing (3) after PTA.
between both groups (Table 3). The tortuorsity and severe
calcification in these regions were considered to be the
reason for this significance. The percentage of stenosis of
the arterial lesions improved from 91.5 + 11.0% before,
to 12.9 + 18.8% after, and the ankle pressure index (API)
increased from 0.49+0.19% before, to 0.91 +0.16% after,
in the cases with clinical success.
A long-term follow-up study of66 months was carried
out on 63 limbs with clinical success by angiography,
measurement of ankle pressure index and clinical symp-
toms except for angioscopy. Consequently, the cumula-
tive patency rate in the follow-up of 66 months was 94%
for the stenotic lesions and 83% for the occlusive lesions
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Table 2 Clinical Success Rate After Laser Angioplasty
(I) Stenotic lesion
Mean length No of Clinical
(cm) lesions success
Femoro-popliteal
lesion 6.4 + 8.5 22 20 (91%)
Iliac lesion 2.0 + 1.4 22 20 (91%)
Total 4.2 + 6.4 44 40 (91%)
(II) Occlusive lesion
Mean length No of Clinical
cm lesions success
Femoro-popliteal
lesion
Iliac lesion
Total
P <0.05
12.6 + 11.4 29 25 (86%)]*
7.7 + 5.1 20 10(50%)]*
10.6 + 9.6 49 35 (71%)
Table3 Clinical SuccessRate in theRelationshipbetween theLocation
and the Length of the Stenotic Changes
(1) Femoro-popliteal lesion
Mean length No. of Clinical
Length (cm) lesions success
< 10cm 3.3 + 2.4 33 32 (97%)]*
> 10cm 22.0 + 9.1 18 13 (72%)]*
Total 9.9 +10.6 51 45 (88%)
*p<0.01
(II) lliac lesion
Mean length No. of Clinical
Length tm lesions success
< 5cm 2.1 + 1.0 28 24 (86%)]*
> 5cm 10.1 + 4.4 14 6 (43%)]*
Total 4.7 + 4.6 42 30 (71%)
*p<0.01
2) Laser Angioplasty For Coronary Arterial Diseases
Laser coronary angioplasty was intraoperatively carried
out for 10 patients with multiple stenoses in a coronary
artery (Table 4).
This included9men andonewoman, ranging in age from
39 to 67 years old with a mean of 58. A metal tip probe
(1.5-2.0mm in diameter) was used with angioscopic guid-
ance, by which laser angioplasty could be safely done in all
cases (Fig. 4). Firstofall, acoronary incision was made lon-
gitudinaly and the angioscope was inserted prior to the
stenotic lesion.Then the characteristicsofthe atheronamous
plaque were observed. Thereafter, the metal tip probe was
passed to the lesion to vaporize the plaques under chilled
heart protection. In the case of laser coronary angioplasty,
the optimal conditions were 4-5 W in output and 2 sec in
irradiation time for each shot. In addition to this, the diam-
eterratiobetweenthe metal tipprobe andthecoronary artery
(%)
100"
90-
80-
70-
60-
50-
40-
30-
20-
10-
0
0
Stenotic lesion 94% N=35
Occlusive lesion 83%( N=28
’s a
//’
3 6 9 12 21 24 27 30. 33 36 63 66
Month in follow-up
Figure3 Cumulativepatency rate afterlaserangioplasty forthe peripheral
was an important factor for the prevention of coronary va-
sospasmduring laserirradiation. That is, asmallersizemetal
tip probe, less than 30% of the diameter of the coronary
artery, should be employed. The patients are doing well
without severe complications throughout the treatment.
Consequently, laser coronary angioplasty was a useful
procedure for multiple stenoses in a coronary artery, sav-
ing time in the operation and maintaining the long-term
patency rate of coronary artery bypass grafting, because
of mininized invasiveness.
DISCUSSION
In recent years, Argon, Nd-YAG, Ho-YAG, and Excimer
lasers have been widely utilized for laser angioplasty
(11,20). The optimal conditions for laser angioplasty by
Argon laser were 6W in output and 3 sec in irradiation
time, or 200 in output and 5 sec in irradiation time in our
serial experimental studies (17,18).
On the other hand, several laser conditions (6-12W in
output, 3-10 sec in irradiation time) have been reported
according to the kind of laser system and laser fiber. At
the time of laser angioplasty, angioscopic and intravascu-
lar ultrasound guidance were necessary to evaluate the
characteristics of the atheromatous plaques and the arter-
ial wall before and afterthe laser ablation. And sometimes,
it was angioscopically recognized that the proximal-and
the distal portions were composed of tight atheromatous
plaques and the middle portion was not occluded or filled
with fresh thrombus.
Based on our clinical experience, laser angioplasty
should be recommended to eliminate, or reduce the stenotic
or occlusive changes of short segments within 10cm in
length for a peripheral artery, and within 2cm in length for
a coronary artery.16 M. OKADA et al.
Table 4 Clinical Experience of Laser Angioplasty for the Coronary Heart Disease
Case Age Sex Symptom CAG
Site ofLaser OTCA
Bypass and its conditions
1) K.N. 59 M UAP LMT (5)
LAD (7)
(9)
RCA (3)
2) I.K. 41 M PIA LAD (6)
(7)
Cx (11)
RCA (1)
3) $.K. 61 F PIA LAD (6)
(9)
Cx (13)
RCA (1)
4) T.Y. 56 M UAP LAD (6)
Cx (13)
RCA (2)
(3)
5) T.Y. 39 M PIA LAD (7,8)
Cx (13)
RCA (2)
6) M.N. 67 M UAP LAD (6)
Cx (14)
RCA (l)
7) T.A. 65 M PIA LAD (6)
Cx (13)
RCA (1)
8) M.M. 65 M UAP LAD (6)
Cx (ll)
(12)
RCA (3)
9) Y.N. 61 M OMI LAD (6)
RCA (2)
10) A.U. 65 M UAP LMT (5)
Cx (14)
RCA (2)
PIA Postinfarction angina
AP Angina pectods
UAP Unstable angina pectoris
90% LAD
75% DI LAD
90% RCA (6 w, 3 see, 3 times)
5O%
90%
75% LAD LAD
99% (6 w, 2 see, 3 times)
100%
9O%
90% LAD RCA
100% RCA (6 w, 3 sec, 7 times)
100%
75% LAD
100% Cx RCA
90% RCA (6 w, 3 see, 5 times)
75%
75% LAD LAD
90% Cx (6 w, 3 see, 3 times)
90% RCA
100% LAD RCA
90% Cx (5 w, 2 sec, 2 times)
75% RCA 6 w, 3 see, 3 times)
100% LAD LAD
99% Cx (6 w, 3 sec, 3 times)
100% RCA
100% LAD
75% Cx LAD
90% RCA (4 w, 2 see, 4 times)
100%
100% LAD RCA
90% RCA (2 w, 2 see, 10 times)
75% LAD LAD
90% Cx (200 C, 5 see, 12 times)
75% RCA
Recently, laser angioplasty has been widely employed
in the United States and European countries. The initial
success rate by laser angioplasty has been reported to be
65-95% in comparison with 70-85% for percutaneous
transluminal angioplasty. In our clinical series, the clini-
cal success rate was 91% in the case of stenotic lesions in
comparison with 71% for occlusive lesions.
Thus, satisfactory results by laser angioplasty were
surely obtained (11,17).
On the other hand, the clinical success rate was 97%
in cases with femoro-popliteal lesions of less than 10cm
in length. Thus, there were slight differences in the laser
effects between stenotic and occlusive lesions as well as
in the relationship between initial success and clinical
success in the long-term period. Cumberland has reported
that 50 of 56 totally occluded arteries were recanalized
by laser and that the ankle pressure index increased from
0.53 before to 0.84 after laser irradiation (12). In addi-
tion to this, technical success was 88% and clinical suc-
cess was77%. In Japan, similarresults havebeenreported
in recent years (19).
In general, complications in laser angioplasty include
hematomas in the inguinal region, the subintimal pathway
of the laser fiber, and dissective change of the artery by
additional PTA. We have also experienced 6 dissections
and 2 subintimal pathways of the arteries by additional
PTA, and intimal injuries of laser probe and guide-wire.
However, there was no urgent surgical intervention for
them.
Thus, there are some differences in the clinical success
due to indication, techniques and antithrombogenic man-
agement after laser angioplasty in several hospitals. On the
other hand, intraoperative coronary laser angioplasty was
a safe and effective procedure under direct vision (20,21).
However, Litvack and Sanborn have reported a high in-
cidence of complications after percutaneous transluminalCLINICAL EXPERIENCE OF LASER ANGIOPLASTY 17
a)
Figure 4
ablation.
b)
Laser coronary angioplasty, a) Endoscopic finding of severe stenosis of the coronary artery, b) Endoscopic findings before and after laser
laser coronary angioplasty (22,23). All cases treated by
laser methods should be followed-up even in the long-
term period.
In conclusion, laser angioplasty was effective to sig-
nificantly open the lumen ofocclusive and stenotic lesions
of the peripheral artery. At present, excellent results have
been revealed within 10cm in length for femoro-popliteal
lesions. On the other hand, satisfactory results were ob-
tained within 5 cm in length for iliac lesions. In the case
of coronary arteries are good indications stenotic lesions
within 2 cm in length. However, the indication for laser
angioplasty will change in the long-term period.18 M. OKADA et al.
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